Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.08% vs 23.23% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.72% vs 126.75% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 4.35% vs 1,825.00% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -12.82% vs 13.04% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Akebia Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.08% vs 23.23% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 43.35% vs -22.70% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -96.72% vs 126.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 102.33% vs 23.21% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 4.35% vs 1,825.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 1,957.14% vs 800.00% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -12.82% vs 13.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 223.81% vs 31.25% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






